For people with Parkinson's disease, higher levels of physical activity were associated with slower declines in thinking and ...
Patients who carry a mutation in the GBA1 gene—the most common genetic risk factor for Parkinson's disease—often experience ...
A new daily pill could help people with Parkinson’s disease live more of their life without symptoms, a trial has found.
The Takeda spinout showed that a high dose of solengepras can shorten the periods during which difficult Parkinson’s disease symptoms like involuntary movements and sleepiness.
Major Parkinson’s breakthrough as new pill offers hope of treating symptoms and has fewer side-effects - Trial found patients on solengepras had 37 minutes less ‘off’ time each day when dopamine drugs ...
The timing of deep brain stimulation (DBS) surgery is a critical factor in preserving cognitive function for Parkinson's ...
Among the many wonders of the brain is its ability to master movements through practice — a dance step, piano sonata, or tying our shoes. For decades, neuroscientists have known that these tasks ...
Alda's first symptoms weren't the typical tremors, stiffness or slow movement. It was throwing a pillow at his wife in his ...
Lundbeck to present progress across its movement disorders pipeline with data in MSA, Parkinson’s disease at MDS 2026: Valby, Denmark Monday, October 5, 2026, 17:00 Hrs [IST] H.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results